Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Brawijaya
About this trial
This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer
Eligibility criteria
Qualifiers
Unbearable cancer pain that is resistant to WHO (World Health Organization) pain ladder at least 2 weeks medication
The patient is tired of taking medication orally or complications of current medication (respiratory depression, nausea, vomiting, opioid-induced constipation, gastrointestinal disturbances)
Patients with pelvic floor pain diagnosed by a (Fellow of Interventional Pain Practice) FIPP-certified pain specialist
Patients with pain in the perineum diagnosed by a FIPP-certified pain specialist
Disqualifiers
Refuse to be included in the research
Blood clotting disorders (including taking anticoagulant drugs)
Local infection in the area of action
Loss to follow up
Trial design
Treatments tested in this trial
- Superior Hypogastric Plexus Block
- Ganglion Impar Block
Treatment groups
36 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov